4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000899243-22-001378
Options or other derivatives
- Director acquired 2,214 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| THOMAS FRANK E Director | 2022-01-05 | Grant or award · Stock Option (Right to Buy) | +2,214 | $9.03 | $19,992 | 2,214 | D |
Loading xslF345X03/doc4.xml…